InvestSMART

Sonic Healthcare Limited (ASX:SHL)

ALERT: Price-sensitive ASX Announcement for SHL
Current share price for SHL : $21.225 -0.015 (-0.07%)+
Announcement
Release
19 Feb 2026 8:50AM
Price at Release
$21.240
Full Release
download
Summary
Sonic Healthcare Limited reported its half-year results for the period ending 31 December 2025, showcasing strong revenue growth of 17% to A$5.445 billion and an 11% increase in net profit to A$262 million. The company's earnings per share improved by 8%, demonstrating solid financial performance amidst global operations. Sonic Healthcare maintained its guidance for the full fiscal year 2026, with an EBITDA target between A$1.87 and A$1.95 billion. The company continues to focus on capital management, including maintaining an investment-grade balance sheet, undertaking selective acquisitions such as LADR and Cairo Diagnostics, and engaging in share buybacks. Operational highlights include significant growth in Germany and the UK, integration efforts in the US, and ongoing investments in infrastructure and technology. The interim dividend was set at $0.45, 60% franked, with a payment date of 19 March 2026.
Key Points
  • Revenue growth of 17% to A$5.445 billion.
  • Net profit increased by 11% to A$262 million.
  • EPS improved by 8%.
  • EBITDA guidance for FY 2026 maintained.
  • Strong performance in Germany and UK markets.
  • Ongoing integration and restructuring in the US.
  • Focus on capital management and operational efficiency.
  • Interim dividend declared at $0.45, 60% franked.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should refer to the full announcement here for further information.